Читать книгу Blood and Marrow Transplantation Long Term Management - Группа авторов - Страница 19

1 1. D'Souza A, Fretham C, Lee SJ, et al. Current use of and trends in hematopoietic cell transplantation in the United States. Biol Blood Marrow Transplant, 2020.

2 2. Blume KGT, E. D. Chapter 1: A history of allogeneic and autologous hematopoietic cell transplantation (ed Fifth). Oxford, UK, John Wiley & Sons, Ltd, 2015 pp. 1–11

3 3. Horowitz MM. Chapter 2: Uses and Growth of Hematopoietic Cell Transplantation (ed Fifth). Oxford, UK, John Wiley & Sons, Ltd, 2015 pp. 8–17.

4 4. Savani BM (Editor). Blood and marrow transplantation long‐term management: prevention and complications (ed First). Oxford, UK, John Wiley & Sons, Ltd, 2013.

5 5. Shah NN, Ahn KW, Litovich C, et al. Allogeneic transplantation in elderly patients >/=65 years with non‐Hodgkin lymphoma: a time‐trend analysis. Blood Cancer J 9:97, 2019.

6 6. Cooper JP, Storer BE, Granot N, et al. Allogeneic hematopoietic cell transplantation with non‐myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades. Haematologica, 2020.

7 7. Canaani J, Beohou E, Labopin M, et al. Trends in patient outcome over the past two decades following allogeneic stem cell transplantation for acute myeloid leukaemia: an ALWP/EBMT analysis. J Intern Med 285:407–418, 2019.

8 8. Bakhtiar S, Salzmann‐Manrique E, Hutter M, et al. AlloHSCT in paediatric ALL and AML in complete remission: improvement over time impacted by accreditation? Bone Marrow Transplant 54:737–745, 2019

9 9. Khoury HJ, Wang T, Hemmer MT, et al. Improved survival after acute graft‐versus‐host disease diagnosis in the modern era. Haematologica 102:958–966, 2017.

10 10. Kanate AS, Majhail NS, Savani BN, et al. Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: guidelines from the American Society for Transplantation and Cellular Therapy. Biol Blood Marrow Transplant 26:1247–1256, 2020.

11 11. Hashmi S, Carpenter P, Khera N, et al. Lost in transition: the essential need for long‐term follow‐up clinic for blood and marrow transplantation survivors. Biol Blood Marrow Transplant 21:225–232, 2015.

12 12. Hashmi SK, Lee SJ, Savani BN, et al: ASBMT Practice Guidelines Committee Survey on Long‐Term Follow‐Up Clinics for Hematopoietic Cell Transplant Survivors. Biol Blood Marrow Transplant 24:1119–1124, 2018.

13 13. Savani BN, Griffith ML, Jagasia S, et al. How I treat late effects in adults after allogeneic stem cell transplantation. Blood 117:3002–3009, 2011.

14 14. Majhail NS, Rizzo JD, Lee SJ, et al. Recommended screening and preventive practices for long‐term survivors after hematopoietic cell transplantation. Biol Blood Marrow Transplant 18:348–371, 2012.

15 15. Bhatia S, Armenian SH, Landier W. How I monitor long‐term and late effects after blood or marrow transplantation. Blood 130:1302–1314, 2017.

16 16. Inamoto Y, Lee SJ. Late effects of blood and marrow transplantation. Haematologica 102:614–625, 2017.

17 17. Savani BN, Tichelli A (Editors). Blood and marrow transplantation long‐term management: prevention and complications (ed Second). Oxford, UK, John Wiley & Sons, Ltd, 2020.

18 18. Battiwalla M, Hashmi S, Majhail N, et al. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: developing recommendations to improve survivorship and long‐term outcomes. Biol Blood Marrow Transplant 23:6–9, 2017.

19 19. Martin PJ, Counts GW, Jr., Appelbaum FR, et al. Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation. J Clin Oncol 28:1011–1016, 2010.

20 20. Bhatia S, Francisco L, Carter A, et al: Late mortality after allogeneic hematopoietic cell transplantation and functional status of long‐term survivors: report from the Bone Marrow Transplant Survivor Study. Blood 110:3784–3792, 2007.

21 21. Palmer J, Chai X, Pidala J, et al: Predictors of survival, nonrelapse mortality, and failure‐free survival in patients treated for chronic graft‐versus‐host disease. Blood 127:160–166, 2016.

22 22. Sun CL, Francisco L, Kawashima T, et al: Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. Blood 116:3129–3139; quiz 3377, 2010.

23 23. Battiwalla M, Tichelli A, Majhail NS. Long‐term survivorship after hematopoietic cell transplantation: roadmap for research and care. Biol Blood Marrow Transplant 23:184–192, 2017.